Corel Pharma Chem (India) Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
- Paid Up Capital ₹ 2.00 Cr
- Company Age 4 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth %
- Ebitda
- Net Worth
- Total Assets 166.86%
About Corel Pharma Chem (India)
Corel Pharma Chem (India) Private Limited (CPCIPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 October 2020 (Four years and four months 16 days old ). Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Manufacturing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 2.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Neeru Patel, Kiritkumar Patel, Deepan Patel, and One other member serve as directors at the Company.
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24299GJ2020PTC117155
- Company No.
117155
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Oct 2020
- Date of AGM
18 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Corel Pharma Chem (India)?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Neeru Patel  | Director | 04-Jan-2022 | Current |
| Kiritkumar Patel | Director | 09-Oct-2020 | Current |
| Deepan Patel | Director | 09-Oct-2020 | Current |
| Dhara Patel | Director | 04-Jan-2022 | Current |
Financial Performance of Corel Pharma Chem (India).
Corel Pharma Chem (India) Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Corel Pharma Chem (India)?
Unlock access to Corel Pharma Chem (India)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Corel Pharma Chem Private LimitedKiritkumar Patel and Deepan Patel are mutual person
C D Commodities Broking LimitedKiritkumar Patel is a mutual person
Universal Medicap LimitedKiritkumar Patel is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Corel Pharma Chem (India)?
Unlock and access historical data on people associated with Corel Pharma Chem (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Corel Pharma Chem (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Corel Pharma Chem (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.